Figure 1C–E show that the serum activity of ALT, AST, and ALP was markedly elevated in the group challenged with ZEA (p < 0.05), indicating that ZEA infection was successfully established. Interestingly, pretreatment with ZER effectively brought down the serum activity of ALT, AST, and ALP. These results suggested that ZEA-induced liver disorders can be controlled with ZER owing to the latter’s hepatoprotective properties. Figure 1F,G and Table S1 show that the body and liver weight showed no significant variation between the control group and test subjects. Here, GPT is linked to liver disorder.